iNova Pharmaceuticals Executive and Leadership Team

Daniel Spira, the Chief Executive Officer at iNova Pharmaceuticals, directs the overarching corporate strategy and operational execution. Spira guides the company's expansion across Asia, Australia and New Zealand, and Africa, ensuring alignment with market demands and long-term growth objectives. This leadership role involves fostering innovation in product development and market penetration for both prescription medicines and consumer health products. Spira drives the company's mission to improve health outcomes through accessible and effective pharmaceutical solutions. Overseeing all functional departments, Daniel Spira ensures cohesive strategic planning and resource allocation to meet global health challenges and capitalize on emerging market opportunities. The Chief Executive Officer's purview encompasses financial performance, regulatory compliance, and stakeholder relations, solidifying iNova Pharmaceuticals' position as a key player in the international healthcare sector.

William Foo, the Group Chief Financial Officer at iNova Pharmaceuticals, directs all financial planning, accounting, and reporting functions for the international organization. Foo manages capital allocation, investment strategies, and financial risk management to support the development, marketing, and sale of prescription medicines and consumer health products. This critical role ensures the financial health and sustainability of iNova Pharmaceuticals' operations across Asia, Australia and New Zealand, and Africa. William Foo oversees budgeting, forecasting, and treasury operations, providing essential financial insights to guide strategic decision-making. The Group Chief Financial Officer's leadership ensures compliance with global financial regulations and optimizes profitability. By maintaining robust financial controls and driving fiscal discipline, Foo underpins the company's capacity for continued expansion and innovation in the healthcare market.

Paul Smith, the Chief Operating Officer at iNova Pharmaceuticals, manages the day-to-day operational activities and optimizes business processes across all regions. Smith ensures efficient supply chain management and manufacturing operations, critical for delivering a wide range of prescription medicines and consumer health products. This role focuses on enhancing operational scalability and cost-effectiveness to support iNova Pharmaceuticals' global reach in Asia, Australia and New Zealand, and Africa. Paul Smith oversees the integration of new technologies and best practices to streamline operations and maintain high product quality standards. The Chief Operating Officer's responsibilities include driving operational excellence, managing cross-functional teams, and ensuring seamless execution of strategic initiatives. By focusing on operational efficiency, Smith directly contributes to the company's ability to meet diverse market needs and maintain a competitive edge in the pharmaceutical industry.

Sacha Ernst, the President (Asia) at iNova Pharmaceuticals, spearheads the strategic direction and commercial operations within the Asian market. Ernst drives market penetration and sales growth for the company's extensive portfolio of prescription medicines and consumer health products across this key region. This leadership position involves cultivating strong relationships with healthcare providers, distributors, and regulatory bodies throughout Asia. Sacha Ernst oversees regional teams, ensuring alignment with global corporate objectives while adapting strategies to local market dynamics and consumer needs. The President (Asia)'s focus is on expanding iNova Pharmaceuticals' footprint and impact, delivering innovative health solutions to a diverse population. Ernst's strategic oversight is crucial for navigating the complexities of the Asian pharmaceutical landscape and achieving sustained commercial success.

Andrew Jenkin, the President, , Zealand (Canada, Australia) at iNova Pharmaceuticals, leads the strategic initiatives and commercial activities across Australia and New Zealand, and Canada. Jenkin is responsible for driving the market presence and sales performance of iNova Pharmaceuticals' diverse product lines, including prescription medicines and consumer health products, within these territories. This executive role involves managing regional operations, fostering key partnerships, and ensuring compliance with local healthcare regulations. Andrew Jenkin oversees the development and execution of market-specific strategies designed to meet the unique health needs of populations in Australia, New Zealand, and Canada. The President's leadership ensures that iNova Pharmaceuticals effectively serves these critical markets, contributing to the company's global mission of improving health and well-being through accessible pharmaceutical solutions.

Johan Rempel, the President at iNova Pharmaceuticals, directs strategic growth and operational oversight for key market segments. Rempel focuses on expanding the company's reach and impact through the development and distribution of a comprehensive range of prescription medicines and consumer health products. This leadership role involves navigating complex market dynamics and regulatory environments to ensure iNova Pharmaceuticals' continued success. Johan Rempel oversees regional business units, driving performance and fostering innovation to meet evolving healthcare demands. The President's mandate includes enhancing market share and solidifying the company's reputation for quality and efficacy. Rempel's strategic vision and operational acumen are vital for achieving iNova Pharmaceuticals' objectives in its target geographies.